Skip to main content

Table 3 Characteristics of the study subjects

From: Development and evaluation of a machine learning model for osteoporosis risk prediction in Korean women

Categories

Variables

Total

(n = 4199)

Non-osteoporosis

(n = 3393)

Osteoporosis

(n = 806)

P value

Socio-demographic characteristics

Age (year)

52, 44

49, 44

61, 56

< 0.001b

40–49 (n, %)

1850 (44.1)

1768 (52.1)

82 (10.2)

 

50–59 (n, %)

1118 (26.6)

872 (25.7)

246 (30.5)

 

60–69 (n, %)

1231 (29.3)

753 (22.2)

478 (59.3)

 

Education (n, %)

   

< 0.001

≤ Elementary

1928 (45.9)

1338 (39.4)

590 (73.2)

 

Middle school

974 (23.2)

866 (25.5)

108 (13.4)

 

High school

1053 (25.1)

956 (28.2)

97 (12.0)

 

≥ College

244 (5.8)

233 (6.9)

11 (1.4)

 

Income level

(million KRW/month)

   

< 0.001

< 2

2960 (70.5)

2273 (67.0)

687 (85.2)

 

2–3.99

1000 (23.8)

905 (26.7)

95 (11.8)

 

≥ 4

239 (5.7)

215 (6.3)

24 (3.0)

 

Anthropometric parameters

Height (cm)

153.8 ± 0.1

154.3 ± 0.1

151.6 ± 0.2

< 0.001a

Weight (kg)

58.9 ± 0.1

58.8 ± 0.1

59.3 ± 0.3

0.435 a

BMI (kg/m2)

24.9 ± 0.0

24.7 ± 0.1

25.8 ± 0.1

< 0.001 a

Waist circumference (cm)

81.7 ± 0.1

80.8 ± 0.2

85.7 ± 0.3

< 0.001 a

Hip circumference (cm)

93.6 ± 0.1

93.5 ± 0.1

93.9 ± 0.2

0.201 a

Body fat (%)

31.9, 28.4

31.6, 28.1

33.4, 30.1

< 0.001b

Muscle mass (kg)

37.7 ± 0.1

37.9 ± 0.1

37.0 ± 0.2

< 0.001 a

Blood pressure (mmHg)

    

SBP

122, 110

120, 108

130, 120

< 0.001b

DBP

80, 72

80, 72

84, 78

< 0.001b

Lifestyle factors

Alcohol intake

status (n, %)

   

< 0.001

Current

1058 (25.2)

909 (26.8)

149 (18.5)

 

Former

129 (3.1)

105 (3.1)

24 (3.0)

 

Never

3012 (71.7)

2379 (70.1)

633 (78.5)

 

Alcohol intake

(g/day)

0.0, 0.0

0.0, 0.0

0.0, 0.0

< 0.001b

Smoking status

(n, %)

   

0.155

Current

143 (3.4)

117 (3.4)

26 (3.3)

 

Former

56 (1.3)

39 (1.1)

17 (2.1)

 

Never smoked

4000 (95.3)

3237 (95.4)

763 (94.7)

 

Average sleep

time (hours)

7, 6

7, 6

7, 6

0.003b

< 7 (n, %)

1880 (44.8)

1553 (45.8)

327 (40.6)

 

7–9 (n, %)

2214 (52.7)

1768 (52.1)

446 (55.3)

 

> 9 (n, %)

105 (2.5)

72 (2.1)

33 (4.1)

 

Insomnia (n, %)

896 (21.3)

664 (19.6)

232 (28.8)

< 0.001

Sleep hardness

(n, %)

709 (16.9)

520 (15.3)

189 (23.4)

< 0.001

Physical activity

(≥ 30 min/day)

    

High-intensity

1357 (32.3)

1033 (30.4)

324 (40.2)

< 0.001

Moderate-intensity

1411 (33.6)

1176 (34.7)

235 (29.2)

0.052

Low-intensity

3856 (91.8)

3137 (92.5)

719 (89.2)

0.020

Sedentary

3703 (88.2)

3010 (88.7)

693 (86.0)

0.060

Stable

2142 (51.0)

1763 (52.0)

379 (47.0)

0.014

Coffee consumption (n, %)

   

< 0.001

0 cup/week

1198 (28.5)

902 (26.6)

296 (36.7)

 

< 1 cup/week

281 (6.7)

224 (6.6)

57 (7.1)

 

1–6 cup/week

712 (17.0)

584 (17.2)

128 (15.9)

 

1 cup/day

1230 (29.3)

1014 (29.9)

216 (26.8)

 

≥ 2 cup/day

778 (18.5)

669 (19.7)

109 (13.5)

 

Reproductive factors

Menopausal status (yes) (n, %)

2654 (63.2)

1911 (56.3)

743 (92.2)

< 0.001

Age at menopause (year)

47, 45

47, 45

48, 45

0.147b

Age at menarche (year)

16, 15

16, 14

16, 15

< 0.001b

Pregnancy experience

(yes) (n, %)

4157 (99.0)

3359 (99.0)

798 (99.0)

0.981

Breast cancer

surgery (n, %)

24 (0.6)

18 (0.5)

6 (0.7)

0.469

Nutrient intakes

Energy (Kcal/day)

1681.5, 1383.3

1692.3, 1395.1

1640.6, 1345.4

0.008b

Carbohydrate (g/day)

301.9, 259.6

302.7, 260.1

298.9, 258.0

0.780b

Protein (g/day)

55.6 ± 0.4

56.1 ± 0.4

53.3 ± 0.9

< 0.001a

Fat (g/day)

28.9 ± 0.3

29.7 ± 0.3

25.6 ± 0.7

< 0.001a

Fiber (g/day)

20.6 ± 0.2

20.6 ± 0.2

20.6 ± 0.4

0.244a

Calcium (mg/day)

384.2, 266.0

392.5, 270.7

347.0, 243.1

< 0.001b

Phosphorus (mg/day)

877.8, 661.5

887.4, 669.4

847.3, 623.3

0.002b

Magnesium (mg/day)

106.0, 52.8

105.7, 53.9

108.5, 49.0

0.515b

Sodium (mg/day)

2170.0 ± 20.3

2178.3 ± 22.5

2135.2 ± 47.6

0.024a

Potassium (mg/day)

2637.8 ± 20.7

2637.9 ± 22.4

2637.7 ± 51.7

0.178a

Iron (mg/day)

12.2 ± 0.1

12.2 ± 0.1

12.2 ± 0.2

0.365a

Zinc (mg/day)

10.7, 8.4

10.8, 8.4

10.4, 8.2

0.074b

Copper (µg/day)

598.3, 339.6

600.8, 341.3

587.0, 335.4

0.766b

Selenium (µg/day)

35.7 ± 0.4

36.8 ± 0.4

31.0 ± 1.0

< 0.001a

Manganese (mg/day)

2.1, 0.9

2.1, 0.9

2.2, 0.9

0.545b

Cholesterol (mg/day)

127.2, 72.2

133.6, 77.4

98.1, 58.7

< 0.001b

Retinol (µg/day)

64.6, 31.7

67.5, 34.6

48.5, 21.6

< 0.001b

Beta-carotene (µg/day)

2423.6 ± 28.1

2459.1 ± 31.3

2274.0 ± 63.6

< 0.001a

Vitamin D

(µg/day)

1.9, 0.9

2.1, 1.0

1.4, 0.6

< 0.001b

Vitamin E

(mg/day)

9.9 ± 0.1

10.0 ± 0.1

9.5 ± 0.2

< 0.001a

Vitamin K

(µg/day)

100.1, 59.6

102.0, 62.0

90.5, 50.4

< 0.001b

Vitamin B6

(mg/day)

1.8 ± 0.0

1.8 ± 0.0

1.7 ± 0.0

< 0.001a

Vitamin C

(mg/day)

142.9 ± 2.2

142.0 ± 2.3

146.8 ± 5.9

0.161a

Diet quality indices

INQ

1.0, 0.8

1.0. 0.8

1.0, 0.8

0.280b

KHEI

43.6 ± 0.2

44.1 ± 0.2

41.8 ± 0.4

< 0.001a

DII

2.2, 1.7

2.2, 1.7

2.4, 1.8

< 0.001b

NEAP

37.7 ± 0.2

38.0 ± 0.2

36.2 ± 0.4

< 0.001a

PRAL

14.8, 7.1

15.3, 7.6

13.2, 5.0

< 0.001b

aMED

4, 3

4, 3

4, 3

0.928b

DASH

25, 22

25, 22

25, 23

0.014b

Medical history

Hypertension (n, %)

759 (18.1)

537 (15.8)

222 (27.5)

< 0.001

Diabetes mellitus

(n, %)

263 (6.3)

198 (5.8)

65 (8.1)

0.019

Allergic diseases

(n, %)

275 (6.5)

236 (7.0)

39 (4.8)

0.029

Myocardial infarction (n, %)

30 (0.7)

24 (0.7)

6 (0.7)

0.911

Thyroid disease

(n, %)

209 (5.0)

170 (5.0)

39 (4.8)

0.840

Congestive heart failure (n, %)

9 (0.2)

7 (0.2)

2 (0.2)

0.817

Coronary artery disease (n, %)

37 (0.9)

30 (0.9)

7 (0.9)

0.966

Hyperlipidemia (n, %)

88 (2.1)

70 (2.1)

18 (2.2)

0.762

Asthma (n, %)

112 (2.7)

89 (2.6)

23 (2.9)

0.715

COPD (n, %)

18 (0.4)

17 (0.5)

1 (0.1)

0.141

Kidney disease

(n, %)

147 (3.5)

119 (3.5)

28 (3.5)

0.963

Cerebrovascular disease (n, %)

46 (1.1)

34 (1.0)

12 (1.5)

0.233

Gout (n, %)

391 (9.3)

279 (8.2)

112 (13.9)

< 0.001

Arthritis (n, %)

937 (22.3)

661 (19.5)

276 (34.2)

< 0.001

Medication history

Steroids

14 (0.3)

13 (0.4)

1 (0.1)

0.251

Oral contraceptives

42 (1.0)

36 (1.1)

6 (0.7)

0.417

Insulin medication

38 (0.9)

30 (0.9)

8 (1.0)

0.770

Hypertension medication

593 (14.1)

411 (12.1)

182 (22.6)

< 0.001

Arthritis medication

268 (6.4)

190 (5.6)

78 (9.7)

< 0.001

Thyroid medication

110 (2.6)

88 (2.6)

22 (2.7)

0.828

Hormone replacement

therapy

184 (4.4)

168 (5.0)

16 (2.0)

< 0.001

Osteoporosis medication

144 (3.4)

99 (2.9)

45 (5.6)

< 0.001

Stroke medication

11 (0.3)

7 (0.2)

4 (0.5)

0.148

Asthma medication

48 (1.1)

40 (1.2)

8 (1.0)

0.655

Hyperlipidemia medication

27 (0.6)

20 (0.6)

7 (0.9)

0.373

Anticonvulsants

1 (0.0)

1 (0.0)

0 (0.0)

0.626

Anticoagulants

1 (0.0)

0 (0.0)

1 (0.1)

0.040

Family history

Osteoporosis

    

Parents

141 (3.4)

134 (3.9)

7 (0.9)

< 0.001

Siblings

23 (0.5)

17 (0.5)

6 (0.7)

0.400

Other

2 (0.0)

2 (0.1)

0 (0.0)

0.491

Biochemical parameters

Albumin (g/dL)

4.1, 4.0

4.1, 4.0

4.1, 4.0

0.025b

Creatinine (mg/dL)

0.7, 0.7

0.7, 0.7

0.7, 0.7

0.180b

AST (IU/L)

25.0, 22.0

25.0, 22.0

26.0, 22.0

< 0.001b

ALT (IU/L)

19.0, 16.0

19.0, 16.0

21.0, 17.0

< 0.001b

Total-C (mg/dL)

192.2 ± 0.6

190.1 ± 0.6

201.0 ± 1.3

< 0.001 a

HDL-C (mg/dL)

44.0, 39.0

45.0, 39.0

43.0, 37.0

< 0.001b

Total protein

(g/dL)

7.2, 7.0

7.2, 7.0

7.2, 7.0

0.367b

Calcium (mg/dL)

9.6, 9.3

9.6, 9.3

9.6, 9.3

0.125b

Sodium (mmol/L)

143.0, 141.0

142.0, 141.0

143.0, 142.0

< 0.001b

CRP (mg/dL)

0.1, 0.1

0.1, 0.1

0.2, 0.1

< 0.001b

HbA1c (%)

5.6, 5.3

5.6, 5.3

5.7, 5.5

< 0.001b

TG (mg/dL)

127.0, 95.0

123.0, 93.0

143.0, 108.0

< 0.001b

WBC (103/µL)

6.4 ± 0.0

6.4 ± 0.0

6.4 ± 0.1

0.349 a

Hematocrit (%)

38.1, 36.3

38.1, 36.1

38.5, 36.9

< 0.001b

Hemoglobin (g/dL)

12.6, 12.0

12.6, 12.0

12.7, 12.2

< 0.001b

BUN (mg/dL)

13.8 ± 0.1

13.5 ± 0.1

14.7 ± 0.2

< 0.001 a

Renin (ng/mL/hour)

2.2 ± 0.0

2.2 ± 0.0

2.2 ± 0.1

0.017 a

eGFR (mL/min/1.73m2)

202.7, 169.8

207.0, 174.6

194.3, 157.1

< 0.001b

HOMA–IR

1.5, 1.1

1.5, 1.1

1.7, 1.2

< 0.001b

Genetic factors

rs7529390

   

0.005

AA

58 (1.4)

41 (1.2)

17 (2.1)

 

AC

839 (20.0)

653 (19.2)

186 (23.1)

 

CC

3302 (78.6)

2699 (79.5)

603 (74.8)

 

rs628948

   

0.469

AA

1216 (29.0)

973 (28.7)

243 (30.1)

 

GA

2077 (49.5)

1676 (49.4)

401 (49.8)

 

GG

906 (21.6)

744 (21.9)

162 (20.1)

 

rs238340

   

0.005

GG

142 (3.4)

116 (3.4)

26 (3.2)

 

GT

1400 (33.3)

1092 (32.2)

308 (38.2)

 

TT

2657 (63.3)

2185 (64.4)

472 (58.6)

 

rs6752877

   

0.684

AA

3959 (94.3)

3194 (94.1)

765 (94.9)

 

CA

235 (5.6)

195 (5.7)

40 (5.0)

 

CC

5 (0.1)

4 (0.1)

1 (0.1)

 

rs2722298

   

< 0.001

CC

2706 (64.4)

2234 (65.8)

472 (58.6)

 

TC

1347 (32.1)

1042 (30.7)

305 (37.8)

 

TT

146 (3.5)

117 (3.4)

29 (3.6)

 

rs13182402

   

0.399

CC

15 (0.4)

12 (0.4)

3 (0.4)

 

CT

288 (6.9)

224 (6.6)

64 (7.9)

 

TT

3896 (92.8)

3157 (93.0)

739 (91.7)

 

rs16894980

   

0.335

AA

67 (1.6)

51 (1.5)

16 (2.0)

 

AG

908 (21.6)

746 (22.0)

162 (20.1)

 

GG

3224 (76.8)

2596 (76.5)

628 (77.9)

 

rs3212217

   

0.865

CC

1130 (26.9)

911 (26.8)

219 (27.2)

 

GC

2138 (50.9)

1724 (50.8)

414 (51.4)

 

GG

931 (22.2)

758 (22.3)

173 (21.5)

 

rs12100867

   

0.235

AA

2167 (51.6)

1768 (52.1)

399 (49.5)

 

GA

1707 (40.7)

1372 (40.4)

335 (41.6)

 

GG

325 (7.7)

253 (7.5)

72 (8.9)

 

rs12590815

   

0.203

AA

118 (2.8)

102 (3.0)

16 (2.0)

 

AG

1118 (26.6)

911 (26.8)

207 (25.7)

 

GG

2963 (70.6)

2380 (70.1)

583 (72.3)

 

rs746219

   

0.097

GG

1977 (47.1)

1619 (47.7)

358 (44.4)

 

TG

1790 (42.6)

1439 (42.4)

351 (43.5)

 

TT

432 (10.3)

335 (9.9)

97 (12.0)

 

rs6064822

   

0.916

AA

32 (0.8)

25 (0.7)

7 (0.9)

 

AG

644 (15.3)

522 (15.4)

122 (15.1)

 

GG

3523 (83.9)

2846 (83.9)

677 (84.0)

 

rs1555364

   

0.970

AA

3518 (83.8)

2841 (83.7)

677 (84.0)

 

GA

646 (15.4)

524 (15.4)

122 (15.1)

 

GG

35 (0.8)

28 (0.8)

7 (0.9)

 
  1. Normally distributed values are presented as means ± standard errors. Non-normally distributed values are shown as medians and interquartile ranges
  2. Categorical variables were analyzed by chi-squared analysis
  3. a Parametric values were analyzed by two-sample t-test
  4. b Non-parametric values were analyzed by Mann-Whitney U test
  5. ALT, alanine aminotransferase; aMED, alternate Mediterranean diet; AST, aspartate aminotransferase; BMI, body mass index; BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; DASH, Dietary Approach to Stop Hypertension; DBP, diastolic blood pressure; DII, dietary inflammatory index; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; HOMA–IR, homeostatic model assessment for insulin resistance; INQ, index of nutritional quality; KHEI, Korean healthy eating index; KRW, Korean won; n, number; NEAP, net endogenous acid production; PRAL, potential renal acid load; SBP, systolic blood pressure; TG, triglycerides; Total-C, total cholesterol; WBC, white blood cell